Cancer and oncology research, spinouts, etc. , including related therapies. Basically, any research or innovation relevant to cancer.
Imagine you could cure cancer by targeting one tiny gene. Imagine that same gene occurred in every major cancer, including breast, prostate, lung, liver and colon. Imagine that the gene is not essential for healthy activity, so you could attack it with few or no negative side effects.
Watch the new “Dare to Venture” video to see how Singh blends computer science and biology.
Engage 2021, Princeton University’s second annual innovation and entrepreneurship conference, will feature a long list of top speakers and panelists presenting over two days, starting Wednesday.
But don’t be confused: The event will be much more than just a college lecture.
Rodney Priestley, the vice dean for innovation at the school, said the virtual event Dec. 1-2 is meant to do as its title suggests: engage.
Engage 2021, Princeton’s second annual innovation and entrepreneurship conference, will be held online Dec. 1 and 2. The conference, which is free and open to everyone, offers opportunities to learn about, and catalyze, the transformation of discoveries into innovations that benefit society — from biomedicine and clean energy to wireless, cryptocurrency and quantum computing.
When Alexander Ploss’ team discovered a compound that blocks the cancer-causing hepatitis B virus in lab experiments, the Princeton associate professor of molecular biology immediately grasped the potential benefit for society. He also knew that laboratory findings typically require additional research before they are ready for testing in patients.
On July 27, the Biotechnology Innovation Organization (BIO) named cancer therapeutics and Princeton spin-out company Kayothera Inc. winner of its 2021 Start-up Stadium competition. The company was selected as the winner from 16 finalist companies who were judged on the strength of their commercially viable cutting-edge technologies and therapeutic solutions.
The Ludwig Princeton Branch, a new branch of the Ludwig Institute for Cancer Research on Princeton’s campus, seeks to fill new research roles investigating cancer metabolism and progression. The roles are Ludwig Princeton Associate Research Scholar and Ludwig Postdoctoral Research Associate at Princeton.
